Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Genetics ; 211(3): 913-923, 2019 03.
Article in English | MEDLINE | ID: mdl-30593492

ABSTRACT

Aberrant activation of the Wnt signal transduction pathway triggers the development of colorectal cancer. The ADP-ribose polymerase Tankyrase (TNKS) mediates proteolysis of Axin-a negative regulator of Wnt signaling-and provides a promising therapeutic target for Wnt-driven diseases. Proteolysis of TNKS substrates is mediated through their ubiquitination by the poly-ADP-ribose (pADPr)-dependent RING-domain E3 ubiquitin ligase RNF146/Iduna. Like TNKS, RNF146 promotes Axin proteolysis and Wnt pathway activation in some cultured cell lines, but in contrast with TNKS, RNF146 is dispensable for Axin degradation in colorectal carcinoma cells. Thus, the contexts in which RNF146 is essential for TNKS-mediated Axin destabilization and Wnt signaling remain uncertain. Herein, we tested the requirement for RNF146 in TNKS-mediated Axin proteolysis and Wnt pathway activation in a range of in vivo settings. Using null mutants in Drosophila, we provide genetic and biochemical evidence that Rnf146 and Tnks function in the same proteolysis pathway in vivo Furthermore, like Tnks, Drosophila Rnf146 promotes Wingless signaling in multiple developmental contexts by buffering Axin levels to ensure they remain below the threshold at which Wingless signaling is inhibited. However, in contrast with Tnks, Rnf146 is dispensable for Wingless target gene activation and the Wingless-dependent control of intestinal stem cell proliferation in the adult midgut during homeostasis. Together, these findings demonstrate that the requirement for Rnf146 in Tnks-mediated Axin proteolysis and Wingless pathway activation is dependent on physiological context, and suggest that, in some cell types, functionally redundant pADPr-dependent E3 ligases or other compensatory mechanisms promote the Tnks-dependent proteolysis of Axin in both mammalian and Drosophila cells.


Subject(s)
Drosophila Proteins/physiology , Poly-ADP-Ribose Binding Proteins/physiology , Wnt Signaling Pathway , Animals , Axin Protein/metabolism , Drosophila Proteins/genetics , Drosophila melanogaster , Poly-ADP-Ribose Binding Proteins/genetics , Proteolysis , Tankyrases/metabolism , Wnt1 Protein/metabolism
2.
Clin Cancer Res ; 19(23): 6506-19, 2013 Dec 01.
Article in English | MEDLINE | ID: mdl-24088735

ABSTRACT

PURPOSE: Acute myeloid leukemia (AML) is an aggressive hematologic neoplasm. Recent evidence has shown the bone marrow microenvironment in patients with AML to be intrinsically hypoxic. Adaptive cellular responses by leukemia cells to survive under low oxygenation also confer chemoresistance. We therefore asked whether therapeutic exploitation of marrow hypoxia via the hypoxia-activated nitrogen mustard prodrug, TH-302, could effectively inhibit AML growth. EXPERIMENTAL DESIGN: We assessed the effects of hypoxia and TH-302 on human AML cells, primary samples, and systemic xenograft models. RESULTS: We observed that human AML cells and primary AML colonies cultured under chronic hypoxia (1% O2, 72 hours) exhibited reduced sensitivity to cytarabine-induced apoptosis as compared with normoxic controls. TH-302 treatment resulted in dose- and hypoxia-dependent apoptosis and cell death in diverse AML cells. TH-302 preferentially decreased proliferation, reduced HIF-1α expression, induced cell-cycle arrest, and enhanced double-stranded DNA breaks in hypoxic AML cells. Hypoxia-induced reactive oxygen species by AML cells were also diminished. In systemic human AML xenografts (HEL, HL60), TH-302 [50 mg/kg intraperitoneally (i.p.) 5 times per week] inhibited disease progression and prolonged overall survival. TH-302 treatment reduced the number of hypoxic cells within leukemic bone marrows and was not associated with hematologic toxicities in nonleukemic or leukemic mice. Later initiation of TH-302 treatment in advanced AML disease was as effective as earlier TH-302 treatment in xenograft models. CONCLUSIONS: Our results establish the preclinical activity of TH-302 in AML and provide the rationale for further clinical studies of this and other hypoxia-activated agents for leukemia therapy.


Subject(s)
Antineoplastic Agents/pharmacology , Leukemia, Myeloid, Acute/drug therapy , Nitroimidazoles/pharmacology , Phosphoramide Mustards/pharmacology , Animals , Antineoplastic Agents/therapeutic use , Apoptosis , Bone Marrow/metabolism , Bone Marrow/pathology , Cell Hypoxia , Cell Line, Tumor , Cell Proliferation/drug effects , DNA Fragmentation , Female , HL-60 Cells , Histones/metabolism , Humans , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Leukemia, Myeloid, Acute/pathology , Mice , Mice, SCID , Nitroimidazoles/therapeutic use , Phosphoramide Mustards/therapeutic use , Phosphorylation , Protein Processing, Post-Translational , Reactive Oxygen Species/metabolism , Tumor Burden/drug effects , Xenograft Model Antitumor Assays
3.
Am J Hosp Palliat Care ; 30(1): 59-67, 2013 Feb.
Article in English | MEDLINE | ID: mdl-22531151

ABSTRACT

OBJECTIVES: To assess the importance and desired timing of end-of-life care (EOLC) discussions among women with gynecologic cancer. METHODS: A questionnaire related to EOLC issues was distributed to patients with gynecologic cancer. Answers were analyzed via SPSS using descriptive statistics. Contingency analysis was done to evaluate for differences among disease status and age regarding preferences for timing of discussions. RESULTS: Patients expressed that addressing EOLC is an important part of their treatment. Most patients were familiar with advanced directives (73.0%), do not resuscitate/do not intubate (88.5%), and hospice (97.5%). Designating someone to make decisions was significantly related to disease status (P = .03) and age (P = 0.02). CONCLUSIONS: Patients are familiar with basic EOLC with optimal timing for discussions at disease progression or when treatment is no longer available.


Subject(s)
Genital Neoplasms, Female/therapy , Hospice Care/statistics & numerical data , Terminal Care/statistics & numerical data , Adult , Advance Directives/statistics & numerical data , Age Factors , Aged , Aged, 80 and over , Decision Making , Female , Humans , Middle Aged , Patient Acuity , Socioeconomic Factors , Time Factors
4.
J Anat ; 214(6): 937-55, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19538637

ABSTRACT

Many gekkotans possess seta-bearing adhesive subdigital pads. Details of setal structure, however, are largely based upon putatively exemplary fibrils deemed typical of the species. Little is known of the pattern of configuration of the setae across the subdigital pads and how great, if any, the variance in structure and dimensions is. To understand setal fields as functional entities, as opposed to individual setae, it is necessary to consider this pattern. Additionally, gekkotans within individual radiations occupy different environments and potentially are substrate-specific in terms of the locomotor surface exploited. To investigate these issues, we herein examine the configuration and dimensions of seven species of the gekkotan genus Rhoptropus, and an outgroup taxon, Chondrodactylus bibronii. All of these taxa are rupicolous and the array of rock surfaces exploited by this cluster of taxa is extensive. Our results show that setal field configuration follows a predictable pattern, both from one digit to another within a species, and between homologous digits and anatomical locations between species. One species, Rhoptropus afer, a more terrestrial taxon, exhibits significantly shorter setae and a smaller subdigital pad area than do its congeners, but exhibits the same overall pattern of setal arrangement. Our findings have implications for the understanding of the evolution of adhesive structures, and for the principles used for generating and manufacturing biomimetic artificial microfibrillar arrays.


Subject(s)
Biological Evolution , Foot/anatomy & histology , Lizards/anatomy & histology , Adhesiveness , Animals , Ecosystem , Lizards/classification , Microfibrils/ultrastructure , Microscopy, Electron, Scanning , Phylogeny , Species Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...